Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia

por Banjar, Haneen, Ranasinghe, Damith, Brown, Fred, Adelson, David, Kroger, Trent, Leclercq, Tamara, White, Deborah, Hughes, Timothy, Chaudhri, Naeem
Publicado 2017

Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling

por Pitson, Stuart M., Xia, Pu, Leclercq, Tamara M., Moretti, Paul A.B., Zebol, Julia R., Lynn, Helen E., Wattenberg, Binks W., Vadas, Mathew A.
Publicado 2005

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells

por Wang, Jueqiong, Lu, Liu, Kok, Chung H., Saunders, Verity A., Goyne, Jarrad M., Dang, Phuong, Leclercq, Tamara M., Hughes, Timothy P., White, Deborah L.
Publicado 2017

An oncogenic role for sphingosine kinase 2

por Neubauer, Heidi A., Pham, Duyen H., Zebol, Julia R., Moretti, Paul A.B., Peterson, Amanda L., Leclercq, Tamara M., Chan, Huasheng, Powell, Jason A., Pitman, Melissa R., Samuel, Michael S., Bonder, Claudine S., Creek, Darren J., Gliddon, Briony L., Pitson, Stuart M.
Publicado 2016